Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.
Attention-deficit hyperactivity disorder (ADHD) is a highly heritable disorder of impaired behavioral inhibition, increased motor activity, and inattention. The norepinephrine transporter (NET, SLC6A2) represents an important candidate gene for contribution to ADHD because it regulates catecholamine extracellular and tissue concentrations and contributes to executive functions disrupted in ADHD, and NET is a target for most effective ADHD therapeutics. We identified four NET coding single nucleotide polymorphisms (SNPs) in two ADHD sample sets; two SNPs produce protein variants (T283M, V245I), one of which, T283M, is a novel variant. Examination of the maternal family members through whom the T283M mutation was transmitted, provided no additional ADHD diagnoses. Given the previous identification of a NET mutation that contributes to a familial tachycardia syndrome, we examined autonomic function to reveal in the proband the highest standing-induced increase in heart rate among the ADHD subjects examined. We measured [3H]NE and [3H]dopamine transport for T283M, V245I, and a previously identified NET variant, T283R. T283M and V245I demonstrated decreased substrate transport, as did T283R, suggesting that the T283 residue is sensitive to mutation. Identification of polymorphic sites within NET, specifically those that produce functional consequences, is one critical step in elucidating the genetic variation contributing to the heritable component of diseases such as ADHD.
Hahn
Maureen K
MK
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. maureen.hahn@vanderbilt.edu
Steele
Angela
A
Couch
R Steven
RS
Stein
Mark A
MA
Krueger
Jessica J
JJ
D000818:Animals; D001289:Attention Deficit Disorder with Hyperactivity / Q000235:genetics* / Q000503:physiopathology; D001692:Biological Transport; D002460:Cell Line; D015331:Cohort Studies; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D051379:Mice; D009154:Mutation; D009638:Norepinephrine / Q000378:metabolism; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide
D050484:Norepinephrine Plasma Membrane Transport Proteins; C493227:SLC6A2 protein, human; D004298:Dopamine; D009638:Norepinephrine
Biol Psychiatry. 2005 Jun 1;57(11):1313-23
15950004
Behav Neurosci. 2001 Aug;115(4):934-9
11508732
Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1580-8
18821566
Mol Psychiatry. 2008 Jun;13(6):624-30
17876324
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):163-73
18957375
Biol Psychiatry. 1999 Nov 1;46(9):1309-20
10560036
J Neurosci. 2003 Jun 1;23(11):4470-8
12805287
Philos Trans R Soc Lond B Biol Sci. 1996 Oct 29;351(1346):1463-70; discussion 1470-1
8941958
J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1154-8
15322419
Nat Rev Genet. 2009 Apr;10(4):241-51
19293820
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
9204677
Neuropsychopharmacology. 2005 Jul;30(7):1374-82
15827573
Science. 2007 Jan 26;315(5811):525-8
17185560
J Pharmacol Exp Ther. 1998 Nov;287(2):733-43
9808704
Nature. 2005 Sep 8;437(7056):215-23
16041361
J Neurosci. 2004 Jan 14;24(2):547-53
14724255
J Psychopharmacol. 1997;11(2):151-62
9208378
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19164-9
17146058
Am J Med Genet. 2002 Apr 8;114(3):255-9
11920844
Mol Psychiatry. 2006 Oct;11(10):934-53
16894395
Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):459-74, xi
18295156
Am J Med Genet. 2002 Aug 8;114(6):665-6
12210284
Prog Neurobiol. 2004 Oct;74(3):167-81
15556286
J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):49-58
10638067
Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):115-8
15719398
J Neurosci. 2000 Oct 15;20(20):7571-8
11027216
Clin Psychol Rev. 2006 Aug;26(4):396-432
16513236
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13473-80
8942959
Biol Psychiatry. 1999 Jan 1;45(1):26-31
9894572
Nat Genet. 2008 Jun;40(6):695-701
18509313
Mol Psychiatry. 2003 Nov;8(11):933-6
14593431
Genes Brain Behav. 2008 Jun;7(4):487-95
18081710
Neuropharmacology. 2005 Nov;49(6):724-36
16171832
Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1564-7
18937296
J Neural Transm (Vienna). 2008;115(2):323-9
17994190
Biol Psychiatry. 2007 Jun 1;61(11):1296-305
17239355
Neuropsychopharmacology. 2009 Aug;34(9):2135-42
19387424
Science. 2004 Aug 6;305(5685):869-72
15297675
Am J Med Genet. 1996 Nov 22;67(6):523-32
8950409
JAMA. 2006 Oct 4;296(13):1609-18
17018806
Pharmacogenetics. 2000 Jul;10(5):397-405
10898109
Biol Psychiatry. 2005 Jun 1;57(11):1385-90
15950012
Behav Brain Res. 2003 Nov 30;146(1-2):43-55
14643458
J Neurochem. 1995 Jul;65(1):111-6
7790854
Psychopharmacology (Berl). 2004 Jun;174(1):25-31
15205875
J Pharmacol Exp Ther. 1998 Nov;287(2):744-51
9808705
Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):38-40
14681910
N Engl J Med. 2000 Feb 24;342(8):541-9
10684912
Electrophoresis. 2002 May;23(10):1499-511
12116161
Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):67-72
15717291
J Neurochem. 2004 Feb;88(4):917-27
14756813
Arch Gen Psychiatry. 1986 Feb;43(2):114-24
3947207
J Clin Psychiatry. 2002 Dec;63(12):1140-7
12523874
Mol Pharmacol. 2005 Aug;68(2):457-66
15894713
Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1392-8
18988193
Pediatrics. 2003 Nov;112(5):e404
14595084
J Neurosci. 2002 Oct 1;22(19):8771-7
12351753
Neuron. 2006 Mar 16;49(6):791-6
16543127